What should we do with asymptomatic carotid stenosis?

Anne L Abbott1, Christopher F Bladin, Christopher R Levi

  • 1National Stroke Research Institute, Austin Health, Melbourne, Victoria 3081, Australia. a.abbott@nsri.org.au

Insights

Prophylactic carotid endarterectomy (CEA) offers limited benefits for asymptomatic severe carotid stenosis. New strategies are needed to identify high-risk patients for stroke prevention and improve surgical outcome monitoring.

Area of Science:

  • Vascular Surgery
  • Neurology
  • Clinical Trial Design

Background:

  • Major randomized trials show small benefits for prophylactic carotid endarterectomy (CEA) in asymptomatic severe carotid stenosis.
  • Improvements in medical management may negate previous surgical advantages.
  • Current practice lacks robust methods for identifying high-stroke-risk patients.

Purpose of the Study:

  • To highlight the need for improved strategies in identifying patients who would benefit from carotid intervention.
  • To emphasize the importance of surgeon-specific complication rates for surgical decision-making.
  • To advocate for enhanced monitoring of surgical outcomes in clinical practice.

Main Methods:

  • Review of existing randomized surgical studies on carotid endarterectomy.
  • Discussion of clinical interpretation variability and interdisciplinary collaboration challenges.
  • Consideration of patient expectations and the need for flexible communication.

Main Results:

  • The benefits of prophylactic CEA were found to be small and potentially offset by medical advancements.
  • Availability of individual surgeon complication rates is crucial for informed surgical consideration.
  • Varied clinical interpretations and specialist referrals impact patient management decisions.

Conclusions:

  • There is a need for better patient selection strategies for carotid intervention.
  • Audited review processes or trial settings are ideal for monitoring patients undergoing CEA.
  • Enhanced understanding of current practice outcomes is essential for optimizing stroke prevention.

Related Concept Videos

Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...